ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,02835
-0,19%
Bitcoin
103.192,26
-0,90%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Acadia Pharmaceuticals Inc (ACAD)

  7. Acadia Pharmaceuticals Inc (ACAD) News

ACAD

Acadia Pharmaceuticals (ACAD)

Acadia Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACAD
DatumZeitQuelleÜberschriftSymbolFirma
17/01/202522h05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
14/01/202515h05Business WireAcadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ACADAcadia Pharmaceuticals Inc
30/12/202423h37PR Newswire (US)Acadia Pharmaceuticals Set to Join S&P SmallCap 600NASDAQ:ACADAcadia Pharmaceuticals Inc
19/12/202422h05Business WireAcadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025NASDAQ:ACADAcadia Pharmaceuticals Inc
16/12/202422h05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202422h05Business WireAcadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 MillionNASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202400h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202400h31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
09/12/202415h00Business WireAcadia Pharmaceuticals Appoints Thomas Garner Chief Commercial OfficerNASDAQ:ACADAcadia Pharmaceuticals Inc
26/11/202422h05Business WireAcadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711NASDAQ:ACADAcadia Pharmaceuticals Inc
21/11/202422h05Business WireAcadia Pharmaceuticals to Participate at Upcoming Investor ConferencesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202402h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202402h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202402h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
15/11/202422h05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
14/11/202412h48Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACADAcadia Pharmaceuticals Inc
06/11/202422h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
06/11/202422h05Business WireAcadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating OverviewNASDAQ:ACADAcadia Pharmaceuticals Inc
05/11/202422h05Business WireAcadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 MillionNASDAQ:ACADAcadia Pharmaceuticals Inc
18/10/202400h41Business WireAcadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
16/10/202422h07Business WireAcadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett SyndromeNASDAQ:ACADAcadia Pharmaceuticals Inc
16/10/202422h07Business WireAcadia Pharmaceuticals annonce l’approbation de DAYBUE™ (trofinétide) par Santé Canada pour le traitement du syndrome de RettNASDAQ:ACADAcadia Pharmaceuticals Inc
16/10/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
08/10/202422h05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
26/09/202422h05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
26/09/202400h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
26/09/202400h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
23/09/202423h14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACADAcadia Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACAD

Kürzlich von Ihnen besucht

DBI
DAX
DAX
TG
BAS
BASF
TG
LHA
Deutsche Lufthansa
NYSE
MRK
Merck
TG
432
Arbor Metals
TG
DBK
Deutsche Bank
NYSE
KO
Coca Cola
COIN
DOGEUSD
Dogecoin
TG
RHM
Rheinmetall
TG
ALV
Allianz
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten